Microbiota and human diseases: dietary correction
https://doi.org/10.21508/1027-4065-2020-65-5-116-125
Abstract
Today, the microbiota is recognized as a new «extracorporeal body» maintaining homeostasis of our body. The value of some microorganisms has already been determined, but the role of most of them is not yet clear. The researchers believe that 81- 99% of all microorganisms in healthy adults have been already identified. The mechanism of interaction of a consortium of microorganisms with each other and with the human body is not fully clarified yet. The species of the microbiota in newborns and children are not completely identified. In modern realities, the clinical significance of normal microflora is not fully understood. There have been published many reports on the direct role of the microbiota as a trigger mechanism for various diseases (atherosclerosis, obesity, type 2 diabetes mellitus, inflammatory bowel disease, irritable bowel syndrome, chronic obstructive pulmonary disease, atopic diseases, depression, autism etc.) and carcinogenesis. The study of communicative bacterial connections can be used for the development of new drugs and new strategic approaches to treatment.
About the Authors
Yu. S. Karpeeva
Saint Petersburg State Pediatrics Medical University
Russian Federation
Russian Federation
V. P. Novikova
Saint Petersburg State Pediatrics Medical University
Russian Federation
Russian Federation
A. I. Khavkin
Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
T. A. Kovtun
Progress JSC
Russian Federation
Russian Federation
Moscow
D. V. Makarkin
Progress JSC
Russian Federation
Russian Federation
Moscow
O. B. Fedotova
All-Russian Research Institute of the Dairy Industry
Russian Federation
Russian Federation
Moscow
References
1. Kozhevnikov A.A., Raskina K.V., Martynova E.Yu, Tyakht A.V., Perfil’ev A.V., Drapkina O.M. et al. Intestinal microbiota: modern concepts of the species composition. RMZh 2017; 17(Special issue): 1244-1247. (in Russ.)
2. Landman C., Qmvrain E. Gut microbiota: Description, role and pathophysiologic implications. Rev Med Interne 2016; 37(6): 418-423. DOI: 10.1016/j.revmed.2015.12.012
3. Ardatskaya M.D., Bel’mer S.V., Do-britsa V.P., Zakharenko S.M., Lazebnik L.B., Minushkin O.N. et al. Colon dysbacteriosis (Disbiosis): modern state of the problem, comprehensive diagnosis and treatment correction. Eksperimental’naia i klinicheskaia gastroenterologiia (Experimental and clinical gastroenterology) 2015; 117(5): 13-50. (in Russ.)
4. Harmsen H.J., de Goffau M.C. The Human Gut Microbiota. Adv Exp Med Biol 2016; 902: 95-108. DOI: 10.1007/978-3-319-31248-4_7
5. Kharitonova L.A., Grigoriev K.I., Borzakova S.N. Human microbiote: how a new scientific paradigm changes medical practice. Eksperimental’naia i klinicheskaia gastroenterologiia (Experimental and clinical gastroenterology) 2019; 161(1): 55-63. DOI: 10.31146/1682-8658-ecg-161-1-55-63 (in Russ.)
6. Rajilic-Stojanovic M., de Vos W.M. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 2014; 38: 996-1047. DOI: 10.1111/1574-6976.12075
7. Usenko D.V. Antibiotic-induced changes in the microbiota of the gastrointestinal tract and their correction. RMJ 2018; 2(II): 96-99. (in Russ.)
8. Sitkin S.I., Tkachenko E.I., Vakhitov T.Ja. Metabolic intestinal dysbiosis and its biomarkers. Eksperimental’naia i klinicheskaia gastroenterologiia (Experimental and clinical gastroenterology) 2016; 12(136): 3-12. (in Russ.)
9. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlef-sen L., Sargent M. et al. Diversity of the Human Intestinal Microbial Flora. Science 2005; 308(5728): 1635-1638. DOI: 10.1126/science.1110591
10. Nardone G, Compare D. The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? United European Gastroenterol J 2015; 3(3): 255-260. DOI: 10.1177/2050640614566846
11. Kornienko E.A., Parolova N.I., Ivanov S.V., Zakharchenko M.M., Polev D.S., Zykin P.A. et al. Metagenome and stomach diseases: interrelation and mutual influence. RMZh «Meditsinskoe obozrenie» 2018; 11: 37-44. (in Russ.)
12. Lv J., Guo L., Liu J.J., Zhao H.P., Zhang J., Wang J.H. Alteration of the esophageal microbiota in Barrett’s esophagus and esophageal adenocarcinoma. World J Gastroenterol 2019; 25(18): 2149-2161. DOI: 10.3748/wjg.v25.i18.2149
13. Yang L., Lu X., Nossa C.W., Francois F, Peek R.M., Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterol 2009; 137(2): 588-597. DOI: 10.1053/j.gas-tro.2009.04.046
14. Иванова И.И., Червинец В.М. Микробиота желудочно-кишечного тракта при хроническом гастрите. Под ред. А.Н. Суворова, В.П. Новиковой, И.Ю. Мельниковой. СПб: ИнформМед, 2014; 94-121. [Ivanova I.I., Chervinets V.M. Microbiota of the gastrointestinal tract in chronic gastritis. A.N. Suvorov, V.P. Novikova, I.Yu. Mel’nikova (eds). SPb: InformMed, 2014; 94-121 (in Russ.)].
15. Budden K.F., Gellatly S.L., Wood D.L.A., Cooper M.A., Morrison M., Hugenholtz P. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol 2017; 15(1): 55-63. DOI: 10.1038/nrmicro.2016.142
16. Khavkin A.I., Kosenko-va T.V., Boitsova E.A., Novikova V.P., Bogdanova N.M. Intestinal microbiota as an epigenetic factor in the formation of food allergies. In: Intestinal microbiota in children: norm, disorders, correction. Bel’mer S.V., Khavkin A.I., Aleshina E.O., Aleshkin A.V., Bekhtereva M.K., Bogdanova N.M. et al. Moscw: Medpraktika-M, 2019; 323-336. (in Russ.)
17. Liu R.T., Rowan-Nash A.D., Sheehan A.E., Walsh R.F.L., Sanzari C.M., Korry B.J., Belenky P. Reductions in anti-inflammatory gut bacteria are associated with depression in a sample of young adults. Brain Behav Immun 2020; 88:308324. DOI: 10.1016/j.bbi.2020.03.026.88:308-324
18. Parkes G.C., Rayment N.B., Hudspith B.N., Petrovska L., Lomer M.C., Brostoff J. et al. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 2012; 24(1): 31-39. DOI: 10.1111/j.1365-2982.2011.01803.x
19. Harsch I.A., Konturek P.C. The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into “Old” Diseases. Med Sci (Basel) 2018; 6(2): 32. DOI: 10.3390/medsci6020032
20. Osadchuk A.M., Davyd-kin I.L., Gricenko T.A., Lebedeva E.A., Petrushin A.E. The role of the microbiota of the gastrointestinal tract in the development of diseases of internal organs. Eksperimental’naia i klinicheskaia gastroenterologiia (Experimental and clinical gastroenterology) 2018; 153(5): 133-139. (in Russ.)
21. Prehn-Kristensen A., Zimmermann A., Tittmann L., Lieb W., Schreiber S., Baving L., Fischer A. Reduced Microbiome Alpha Diversity in Young Patients With ADHD. PLoS One 2018; 13(7): e0200728. DOI: 10.1371/journal.pone.0200728
22. Esaiassen E., Hjerde E., Cavanagh J.P., Simonsen G.S., Klin-genberg C. Norwegian Study Group on Invasive Bifidobacte-rial Infections. Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess Pathogenicity. J Clin Microbiol 2017; 55(7): 2234-2248. DOI: 10.1128/ JCM.00150-17
23. Chen Y.Y., Chen D.Q., Chen L., Liu J.R., Vaziri N.D., Guo Y. et al. Microbiome—metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med 2019; 17: 5. DOI: 10.1186/s12967-018-1756-4
24. Sampaio-Maia B., Simoes-Silva L., Pestana M., Araujo R., Soares-Silva I.J. The Role of the Gut Microbiome on Chronic Kidney Disease. Adv Appl Microbiol 2016; 96: 65-94. DOI: 10.1016/bs.aambs.2016.06.002
25. Rumah K.R., Linden J., Fischetti V.A., Vartanian T. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease. PLoS One 2013; 8: e76359. DOI: 10.1371/journal.pone.0076359
26. Sheng Q., Du H., Cheng X., Cheng X., Tang Y., Pan L. et al. Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites. Oncol Lett 2019; 18(5): 4834-4844. DOI: 10.3892/ol.2019.10841
27. Karlsson F.H., Fk F., Nookaew I., Tremaroli V., Fagerberg B., Petranovic D. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 2012; 3:1245. DOI: 10.1038/ncomms2266
28. Patey O., Bimet F., Riegel P., Halioua B., Emond J.P., Estrangin E. et al. Clinical and molecular study of Coryne-bacterium diphtheriae systemic infections in France. Coryne Study Group. J Clin Microbiol 1997; 35(2): 441-445.
29. Rudresh S.M., Ravi G.S., Alex A.M., Mamatha K.R., Sunitha L., Ramya K.T. Non Diphtheritic Corynebacteria: An Emerging Nosocomial Pathogen in Skin and Soft Tissue Infection. J Clin Diagn Res 2015; 9(12): DC19-21. DOI: 10.7860/JCDR/2015/15580.6977
30. Famularo G., Minisola G., Nicotra G.C., Parisi G., De Simone C. A case report and literature review of Corynebacterium urealyticum infection acquired in the hospital. Intern Emerg Med 2008; 3(3): 293-295. DOI: 10.1007/s11739-008-0120-8
31. Nagla S., Lamyaa S., Sally S., Ghada I., Martin H.B. Coryne-bacterium urealyticum: a comprehensive review of an understated organism. Infect Drug Resist 2015; 8: 129-145. DOI: 10.2147/IDR.S74795
32. McLaughlin J., Watterson S., Layton A.M., Bjourson A.J., Barnard E., McDowell A. Propionibacterium acnes and Acne Vulgaris: New Insights from the Integration of Population Genetic, Multi-Omic, Biochemical and Host-Microbe Studies. Microorganisms 2019; 7(5): 128. DOI: 10.3390/microorgan-isms7050128
33. Sowmiya M., Malathi J., Swarnali S., Padma J.P., Therese K.L., Madhavan H.N. A study on the characterization of Propionibacterium acnes isolated from ocular clinical specimens. Indian J Med Res 2015; 142(4): 438-449. DOI: 10.4103/0971-5916.169209
34. Sasaki M., Klapproth J.-M.A. The Role of Bacteria in the Pathogenesis of Ulcerative Colitis. J Signal Transduct 2012; 2012: 704953. DOI: 10.1155/2012/704953
35. Lidar M., Langevitz P., Shoenfeld Y. The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J 2009; 11(9): 558-563.
36. Allen-Vercoe E., Jobin C. Fusobacterium and Enterobacteri-aceae: Important players for CRC? Immunol Lett 2014; 162: 54-61. DOI: 10.1016/j.imlet.2014.05.014
37. Bhatti M.A., Frank M.O. Vfeillonella parvula meningitis: case report and review of Veillonella infections. Clin Infect Dis 2000; 31(3): 839-840. DOI: 10.1086/314046
38. Yamamoto E.A., Jmrgensen T.N. Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Front Immunol 2019; 10: 3141. DOI: 10.3389/fimmu.2019.03141
39. Burnett-Hartman A.N., Newcomb P.A., Potter J.D. Infectious agents and colorectal cancer: A review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev 2008; 17(11): 2970-2979. DOI: 10.1158/1055-9965.EPI-08-0571
40. Gorkiewicz G., Moschen A. Gut microbiome: a new player in gastrointestinal disease. Virchows Archiv 2018; 472(1): 159-172. DOI: 10.1007/s00428-017-2277-x
41. Cicinelli E., De Ziegler D., Nicoletti R., Colafiglio G., Saliani N., Resta L. et al. Chronic endometritis: correlation among hysteroscopic, histologic, and bacteriologic findings in a prospective trial with 2190 consecutive office hysterosco-pies. Fertil Steril 2008; 89(3): 677-684. DOI: 10.1016/j.fertn-stert.2007.03.074
42. HollerE., ButzhammerP., SchmidK., HundsruckerC., Koest-ler J., Peter K. et al. Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant 2014; 20(5): 640-645. DOI: 10.1016/j.bbmt.2014.01.030
43. Sitkin S.I., Tkachenko E.I., Vakhitov T. Ja., Oreshko L.S., Zhigalova T.N., Avalueva E.B. Metabolome of blood serum and intestinal microbiota in ulcerative colitis and celiac disease. festnik Severo-Zapadnogo gosudarstven-nogo meditsinskogo universiteta im. I.I. Mechnikova 2014; 3(6): 12-22. (in Russ.)
44. Frank D.N., Amand A.L.S., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104(34): 13780-13785. DOI: 10.1073/pnas.0706625104
45. Jhangi S., Gandhi R., Glanz B., Cook S., Nejad P., Ward D. et al. Increased Archaea Species and Changes with Therapy in Gut Microbiome of Multiple Sclerosis Subjects. Neurol 2014; 82(10 Supplement). https://nmeurology.org/content/82/10_Supplement/S24.001
46. Loranskaya I.D, Kha-lif I.L., Boldyreva M.N., Kupaeva VA.. Characteristic of microbiome in infl ammatory bowel disease. Ekspeiimental’naia i klinicheskaia gastroenterologiia (Experimental and clinical gastroenterology) 2018; 153(5): 104-111. (in Russ.)
47. Shen-derov B.A., Yudin S.M., Zagaynova A.V., Shevyreva M.P. The role of commensal gut bacteria in the aetiopathogene-sis of inflamatory bowel disease: Akkermansia muciniphila. Eksperimental’naia i klinicheskaia gastroenterologiia (Experimental and clinical gastroenterology) 2018; 159(11): 4-13. (in Russ.) DOI: 10.31146/1682-8658-ecg-159-11-4-13
48. Spencer M.D., Hamp T.J., Reid R.W., Fischer L.M., Zeis-el S.H., Fodor A.A. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterol 2011; 140: 976— 986. DOI: 10.1053/j.gastro.2010.11.049
49. Gagniere J., Raisch J., Veziant J., Barnich N., Bonnet R., Buc E. et al. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol 2016; 22(2): 501-518. DOI: 10.3748/wjg.v22.i2.501
50. Delday M., Mulder I., Logan E.T., Grant G. Bacteroides the-taiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease. Inflamm Bowel Dis 2019; 25(1): 85-96. DOI: 10.1093/ibd/izy281
51. Atanasova K.R., Yilmaz О. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol Oral Microbiol 2014; 29(2): 55—66. DOI: 10.ni1/omi.12047
52. Ding H.T., Taur Y, Walkup J.T. Gut Microbiota and Autism: Key Concepts and Findings. J Autism Dev Disord 2017; 47(2): 480-489. DOI: 10.1007/s10803-016-2960-9
53. Khavkin A.I., Ippolitov Yu.A, Aleshina E.O., Komarova O.N. Microbiota and diseases of the oral cavity. Eksperimental’naia i klinicheskaia gastroenterologiia (Experimental and clinical gastroenterology) 2015; 6(118): 78-81. (in Russ.)
54. Khavkin A.I. The microflora of the digestive tract. Moscow: Fond sotsi-al’noy pediatrii, 2006; 416. (in Russ.)
55. Khavkin A.I., Volynets G.V., Nikitin A.V. The relationship of the gut microbiome and metabolism of bile acids. Vfopr prakt pediatr (Clinical Practice in Pediatrics) 2020; 15(1): 53-60. (in Russ.) DOI: 10.20953/1817-7646-2020-1-53-60.
56. Komarova O.N., Khavkin A.I. Correlation Between Stress, Immunity and Intestinal Microbiota. Pediatricheskaya farmakologiya (Pediatric pharmacology) 2020; 17(1): 18-24. (in Russ.) DOI:10.15690/pf.v17i1.2078.
57. Bogdanova N.M., Khavkin A.I., Kolobova O.L. Prospects of fermented milk products in children with primary hypolactasia of the adult type. Rossiyskiy Vfest-nik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2020; 65(3): 160-168. (in Russ.) DOI:10.21508/1027-4065-2020-65-3-160-168
58. Khavkin А.1., Fedotova O.B., Volynets G.V., Koshkarova Yu.A, Penkina N.A., Komarova O.N. The results of a prospective comparative openlabel randomised study of the effectiveness of a probiotic- and prebiotic-fortified yogurt in small children after an acute respiratory infection. Vopr Det Dietol (Pediatric Nutrition) 2019; 17(1): 29-37. (in Russ.) DOI: 10.20953/1727-5784-2019-1-29-37
Review
For citations:
Karpeeva Yu.S., Novikova V.P., Khavkin A.I., Kovtun T.A., Makarkin D.V., Fedotova O.B. Microbiota and human diseases: dietary correction. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(5):116-125. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-5-116-125
Views:
1376
Email this article 